COMUNICACION INTERCELULAR
CTS-101
Universidad Autónoma de Madrid
Madrid, EspañaUniversidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2023
-
Sigma-1 receptor agonism exacerbates immune-driven nociception: Role of TRPV1 + nociceptors
Biomedicine and Pharmacotherapy, Vol. 167
2020
-
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): A structured summary of a study protocol for a randomized controlled trial
Trials, Vol. 21, Núm. 1
-
Clinical trial to test the efficacy of melatonin in COVID-19
Journal of Pineal Research
-
The search for translational pain outcomes to refine analgesic development: Where did we come from and where are we going?
Neuroscience and Biobehavioral Reviews, Vol. 113, pp. 238-261
2019
-
Modulation by sigma-1 receptor of morphine analgesia and tolerance: Nociceptive pain, tactile allodynia and grip strength deficits during joint inflammation
Frontiers in Pharmacology, Vol. 10, Núm. FEB
2018
-
Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists
Pharmacological Research, Vol. 131, pp. 224-230